期刊文献+

卡维地洛固体分散体的制备及其体外溶出度的测定 被引量:3

Preparation and In Vitro Dissolubility of Carvedilol Solid Dispersion
暂未订购
导出
摘要 目的 :制备卡维地洛固体分散体 ,提高其溶解度和溶速率。方法 :以聚乙烯吡咯烷酮 (PVP)、聚乙二醇 -6000(PEG -6000)为载体 ,以溶剂法和熔融法制备固体分散体 ,并进行体外溶出度研究。结果 :载体比例越大 ,药物溶出愈快 ;载体比例愈小 ,差异愈显著。载体为PVP所制固体分散体的体外溶出行为总体优于载体为PEG -6000的固体分散体。结论 :本试验所制卡维地洛固体分散体能加速体外溶出 ,提高生物利用度 。 OBJECTIVE:To improve the dissolubility and dissolution rate of carvedilol.METHODS:Carvedilol solid dispersions were prepared using solvent-melting and coevaporation methods with PEG-6000 and PVP as carriers and in vitro dissolubility was studied in simulated gastric juice.RESULTS:The results of in vitro dissolubility test showed that the higher the carrier-car ratio,the faster the drug dissolution.The in vitro dissolubility of solid dispersions with PVP as carrier was faster than that of solid dispersions with PEG-6000 as carrier.CONCLUSION:Accelerating the rate of in vitro release and improving bioavailability,carvedilol solid dispersion was a promising preparation.
作者 杨建彬
出处 《中国药房》 CAS CSCD 2001年第3期146-148,共3页 China Pharmacy
关键词 卡维地洛 固体分散体 溶出度 聚乙二醇 聚乙烯吡咯烷酮 carvedilol solid dispersion in vitro dissolubility polyethylene glycol polyvinylpyrrolidone
  • 相关文献

参考文献4

  • 1RuffoloHR,JrBoyleP,VenuitRP,etalCarvedilol(Kredex):anovelmultipleactioncardiovascularagent[J].DrugToday,1991,27(3):46
  • 2HamburgerSA,BaroneFE,FeuersteinGI,etalCarve-dilol(Kredex)reducesinfarctsizeinacaninemodelofacutemyocardialinfarction[J].Pharmacology,1991,43(3):113
  • 3BrilA,SlivjakM,DiMartinoMJ,etalCardioprotectiveeffectsofcarvedilol,anoveladrenoceptorantagonistwithvasodilatingproperties,inanesthetizedminipigs:comparisonwithpropranolol[J].CardiovaseRes,1992,26(6):27
  • 4方积乾数理统计方法[S].北京:人民卫生出版社,1990 :147

同被引文献33

  • 1张秀珍,邹立家,姚庆强,吴倩,鞠连君.聚维酮碘的剂型研究──Ⅱ.复方聚维酮碘消炎止血贴剂的研制[J].山东医科大学学报,1994,32(1):78-80. 被引量:2
  • 2李亚非,胡蕴玉,吕荣,王纪保.四种可溶性载体对骨形态发生蛋白在小鼠体内诱导成骨活性的影响[J].中华骨科杂志,1997,17(2):117-119. 被引量:25
  • 3.复方丹参滴丸[A]..为欧共体药审委传统立法小组推荐中药优秀产品资料汇编[M].北京:中国医药科技出版社,2002.27.
  • 4Sekiguchi K, Obi N. Studies on absorption of eutectic mixture Ⅰ .A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man[J].Chem Pharm Bull,1961,9(11): 866-869.
  • 5USP X X ,NF X V .Rockville United States Pharmacopoeia Convention[M].1980.368.
  • 6Martindale. The extra pharmacopoeia[M].29th. London: The pharmaceutics press, 1989.1101.
  • 7Serajuddin AT, Sheen PC, AugustineMA. Improved dissolution of a poorly water soluble drug from solid dispersions in PEG:polysorbate 80[J].J Pharm Sci, 1990,79(5): 463.
  • 8Miralles MJ, Mcginty JW, Martin A. Combined water soluble carriers for coprecipitates of toibutamide[J].J Pharm Sci,1982,71(3): 302.
  • 9Hasegawa A, Nakagawa H, Sugimoto I. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form[J]. Chem Pharm Bull, 1985, 33(4):1615.
  • 10Ohnishi N, Yokoyama T, Umeds T, et al. Preparation of sustained released granules of nifedipine using a solid dispersion system and pharmacokinetic study after oral administration to rabbits[J]. Yakugaku Zasshi, 1986,106(12):1131.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部